Published Date: 24 Apr 2023
The treatment of post-metabolic and bariatric surgery (MBS) weight recurrence has been shown to be more effective with semaglutide than liraglutide.
Read Full NewsEli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed better results in patients with the skin disease and obesity in a...
Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.
Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.
South Carolina reported a surge to 962 measles cases on Tuesday, state health data showed, including 12 additional infections since Friday, as officials warned the widening...
As currently written, the instructions could potentially lead to delayed treatment of high glucose levels.
An expansion of higher-level neonatal care has been observed in urban hospitals in the US over the years, whereas rural hospitals have faced a decline in such care capacity, per a recent study.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Mezigdomide Combinations Show Promise in Multiple Myeloma
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
In patients with prostate cancer, second-generation antiandrogens may worsen fatigue, falls, and cognitive decline.
5.
No increased risk of childhood cancer near UK nuclear sites, study finds
1.
Uncovering the Reality of Colon Cancer: A Look at Real Images
2.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
3.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
4.
Bone-on-a-Chip Systems: A Revolutionary Approach to Modeling Hematological Cancers
5.
Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
2.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI
4.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation